TP53 and hepatocellular carcinoma: To this end, we induced multifocal HCC tumors by hydrodynamic delivery of a MYC (Myc)-encoding element together with a CRISPR/Cas9 construct targeting Tp53 (sgTp53; Revia et al., 2022).